Delivery Order SPE2DB22D2006-SPE2DB24FV8YL
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract (SPE2DB22D3004|SPE2DB24FPZ07) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Nexletol 180 mg tablets. The $1,017.34 award has an ultimate completion date of April 15, 2024 and does not utilize a set-aside designation. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order with a ceiling value of $2,586.66 for the provision of NEXLETOL 180 MG TABLET to the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price agreement without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is a $3,453.94 delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The delivery order is for the supply of NEXLETOL 180 MG TABLET, a specialty pharmaceutical product, with a completion date of February 8, 2024. Amerisourcebergen Drug Corp has an indefinite delivery contract (IDC) with DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,846.10 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 29, 2023. The award is for the supply of NEXLETOL 180 MG TABLET, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,098.71 firm fixed-price delivery order is for the supply of NEXLETOL 180 MG TABLET to support military healthcare programs. The contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,383.52, is for the delivery of the pharmaceutical product NEXLETOL 180 MG TABLET UU 30S. The contract has an ultimate completion date of April 8, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,079.04 firm fixed price delivery order is for 4566327881 ! NEXLETOL 180 MG TABLET UU 30S, a pharmaceutical product, with a completion date of November 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, valued at $1,201.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of NEXLETOL 180 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 28, 2025 and is a Firm Fixed Price contract. There is no set-aside designation mentioned in the information provided....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,212.09 delivery order contract is for the provision of NEXLETOL 180 MG TABLET UU 30S. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a vehicle for supplying a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of NEXLETOL 180 MG TABLET, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $4,981.37. The ultimate completion date is September 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV8YLDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of NEXLETOL 180 MG TABLET UU 30S pharmaceutical products. The contract has a ceiling value of $3,714.60 and a period of performance through March 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order was not set aside for any specific business category. Amerisourcebergen Corporation, the parent company of the prime contractor, is a leading global pharmaceutical sourcing and distribution services company.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 3/20/24 |